PT726955E - Proteinas quimericas compreendendo polipeptidos borrelia: suas utilizacoes - Google Patents

Proteinas quimericas compreendendo polipeptidos borrelia: suas utilizacoes

Info

Publication number
PT726955E
PT726955E PT95900453T PT95900453T PT726955E PT 726955 E PT726955 E PT 726955E PT 95900453 T PT95900453 T PT 95900453T PT 95900453 T PT95900453 T PT 95900453T PT 726955 E PT726955 E PT 726955E
Authority
PT
Portugal
Prior art keywords
borrelia
proteins
polipeptidos
quimeric
utilizations
Prior art date
Application number
PT95900453T
Other languages
English (en)
Inventor
John J Dunn
Benjamin J Luft
Original Assignee
Brookhaven Science Ass Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/235,836 external-priority patent/US6248562B1/en
Application filed by Brookhaven Science Ass Llc filed Critical Brookhaven Science Ass Llc
Publication of PT726955E publication Critical patent/PT726955E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT95900453T 1993-11-01 1994-10-27 Proteinas quimericas compreendendo polipeptidos borrelia: suas utilizacoes PT726955E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14819193A 1993-11-01 1993-11-01
US08/235,836 US6248562B1 (en) 1993-11-01 1994-04-29 Chimeric proteins comprising borrelia polypeptides and uses therefor

Publications (1)

Publication Number Publication Date
PT726955E true PT726955E (pt) 2004-08-31

Family

ID=26845620

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95900453T PT726955E (pt) 1993-11-01 1994-10-27 Proteinas quimericas compreendendo polipeptidos borrelia: suas utilizacoes

Country Status (10)

Country Link
EP (1) EP0726955B1 (pt)
AT (1) ATE263836T1 (pt)
AU (1) AU8127494A (pt)
CA (1) CA2175567C (pt)
DE (1) DE69433690T2 (pt)
DK (1) DK0726955T3 (pt)
ES (1) ES2219657T3 (pt)
IL (1) IL111479A0 (pt)
PT (1) PT726955E (pt)
WO (1) WO1995012676A1 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6676942B1 (en) * 1991-08-15 2004-01-13 Smithkline Beecham Biologicals (S.A.) Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
WO2002016422A2 (en) * 2000-08-18 2002-02-28 Research Foundation Of The State University Of New York Recombinant constructs of borrelia burgdorferi
US7008625B2 (en) 1993-11-01 2006-03-07 Research Foundation Of The State University Of New York Recombinant constructs of Borrelia burgdorferi
CA2193870C (en) * 1995-12-25 2000-07-18 Nobuyuki Ise Treponema pallidum fused antigen and assay for anti-treponema pallidum antibodies using the same fused antigen
DE19632862B4 (de) * 1996-08-14 2006-08-03 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe
EP1012269A2 (en) * 1997-09-10 2000-06-28 Symbicom Ab P13 antigens from borrelia
DE19847142A1 (de) * 1998-10-13 2000-04-27 Max Planck Gesellschaft Testkit zur Diagnose von Borreliosen und neue Borrelia-Antigene für die Impfstoffentwicklung
EP1194559B1 (en) 1999-06-18 2006-09-20 Research Foundation Of State University Of New York Groups of borrelia burgdorferi that cause lyme disease in humans
EP1939294A1 (en) * 2000-08-18 2008-07-02 Research Foundation Of State University Of New York Recombinant constructs of borrelia burgdorferi
EP1865062A3 (en) * 2000-08-18 2008-01-09 Research Foundation Of State University Of New York Altered OspA of Borrelia burgdorferi
PT1311540E (pt) * 2000-08-18 2008-03-20 Univ New York State Res Found Ospa de borrelia burgdorferi modificada
WO2008116468A2 (en) 2007-03-26 2008-10-02 Dako Denmark A/S Mhc peptide complexes and uses thereof in infectious diseases
WO2009003493A2 (en) 2007-07-03 2009-01-08 Dako Denmark A/S Mhc multimers, methods for their generation, labeling and use
EP2197908A2 (en) 2007-09-27 2010-06-23 Dako Denmark A/S Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
DK2254592T3 (da) 2008-02-28 2019-09-09 Dako Denmark As MHC-multimerer til Borrelia-diagnostik og sygdom
US10722562B2 (en) 2008-07-23 2020-07-28 Immudex Aps Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
US10369204B2 (en) 2008-10-02 2019-08-06 Dako Denmark A/S Molecular vaccines for infectious disease
CN107641151B (zh) * 2010-05-14 2021-10-01 百深公司 Ospa嵌合体及其在疫苗中的用途
RU2015106742A (ru) 2012-07-27 2016-09-20 Бакстер Интернэшнл Инк. Композиции, содержащие химерные молекулы ospa и способы их применения
CZ2014320A3 (cs) * 2014-05-09 2015-11-18 VÝZKUMNÝ ÚSTAV VETERINÁRNÍHO LÉKAŘSTVÍ, v.v.i. Polyepitopový antigen, vakcinační konstrukt a vakcína pro prevenci lymeské boreliózy
WO2016057562A1 (en) * 2014-10-07 2016-04-14 The Research Foundation For The State University Of New York Recombinant borrelia proteins and methods of use thereof
EP3898666A2 (en) 2018-12-17 2021-10-27 Immudex ApS Panel comprising borrelia mhc multimers
US12364744B2 (en) * 2020-11-25 2025-07-22 Lankenau Institute For Medical Research Methods and compositions for the diagnosis, prophylaxis and treatment of Lyme disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69122240T2 (de) * 1990-03-05 1997-02-13 The United States of America, represented by the Secretary, U.S. Department of Commerce, Washington, D.C. Antigen-wirkende proteine von borrelia burgdorferi
DK0650527T3 (da) * 1991-10-22 2003-07-14 Symbicom Ab Forbedring af Borrelia burgdorferidiagnose og -profylakse
AU6366894A (en) * 1993-03-11 1994-09-26 Regents Of The University Of California, The Methods, compositions, and kits for diagnosing lyme disease

Also Published As

Publication number Publication date
EP0726955B1 (en) 2004-04-07
DE69433690D1 (de) 2004-05-13
ATE263836T1 (de) 2004-04-15
IL111479A0 (en) 1994-12-29
ES2219657T3 (es) 2004-12-01
EP0726955A1 (en) 1996-08-21
DE69433690T2 (de) 2005-03-10
AU8127494A (en) 1995-05-23
DK0726955T3 (da) 2004-08-09
WO1995012676A1 (en) 1995-05-11
CA2175567C (en) 2010-08-10
CA2175567A1 (en) 1995-05-11

Similar Documents

Publication Publication Date Title
PT726955E (pt) Proteinas quimericas compreendendo polipeptidos borrelia: suas utilizacoes
WO1996034107A3 (en) Antiviral proteins, dna coding sequences therefor, and uses thereof
PT100781A (pt) Sequencias de dna codificadoras de proteinas de superficie externa, proteinas contendo as referidas sequencias, obtidas a partir de borrelia burgdorferi, e vacinas contendo as referidas proteinas
DE60140474D1 (de) Sammlung von proteinen mit sich wiederholenden sequenzen (repeat proteins), die repetitive sequenzmodule enthalten
ATE215601T1 (de) Rezeptoren der steroid/thyroid superfamilie von rezeptoren
ATE283916T1 (de) Menschliche metabotropische glutamatrezeptor untertype hmglur7 und verwandte dns-verbindungen
ATE310090T1 (de) Gereinigte coprinus laccasen und nukleinsäuren welche dafür kodieren
DK1015586T3 (da) TIE-receptortyrosinkinaseligandhomologer
SG60387G (en) Recombinant dna, hosts transformed with it and polypeptides; compositions and means containing the polypeptides; dna sequences
ATE323770T1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
DE69840230D1 (de) Polypeptide mit prolyldipeptidylaminopeptidase-aktivität und dafür kodierende nukleinsäuren
DK1311682T3 (da) Rekombinante konstruktioner af Borrelia burgdorferi
PL351277A1 (en) Nucleic acid sequence, dna fragments, recombined dna molecules, live recombined carriers, host cells, proteins and their application, vaccines against lawsonia intracellularis and methods of obtaining them as well as relevant diagnostic tests
DK0870046T3 (da) Levende rekombinant vaccine som indeholder felint herpesvirus type 1, især til behandling af felin infektiös peritonitis
DK0393502T3 (da) Opløselige interferon-gamma-receptorer og fremgangsmåder til fremstilling heraf
DK0643719T3 (da) Nukleinsyresekvenser, som koder for eller er komplementære til nukleinsyresekvenser, som koder for interleukin 9-receptor
DK57487A (da) Humant lymphotoxinpolypeptidderivat og fremgangsmaade til fremstilling deraf, dna-fragment, som koder for derivatet, rekombinante plasmider, som har inkorporeret fragmentet, og biologisk rene kulturer af mikroorganismer indeholdende saadanne plasmider
ATE367827T1 (de) Verfahren zur reduzierung der immunogenizität der variablen regionen von antikörpern
DK0672124T3 (da) Anvendelse af en DNA-sekvens, der koder for et oxalsyre-nedbrydende protein i form af et selektionsgen
DE58908276D1 (de) Verfahren zur Oligomerisation von Hexafluorpropenoxid.
DK1078072T3 (da) Nye peptidfragmenter til oprensning af proteiner
DK130290A (da) Lymfokiner, dna-sekvenser, som koder for disse lymfokiner og farmaceutiske midler indeholdende disse lymfokiner
EP0927763A3 (en) Novel aroA
GB2283974A (en) Allatostatins and their use
DK438883D0 (da) 1,2,3,4-tetrahydro-1-aminomethyl-4-phenyl-isoquinoliner, samt fremgangsmade til fremstilling heraf